<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-13T10:17:09+00:00">
  <iati-activity last-updated-datetime="2026-11-13T10:17:09+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BLZ-H-MET-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>To reduce the high rates of AIDS-related deaths and accelerate the reduction in new HIV infections - Belize (01-Jan-2025-31-Dec-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Belize, HIV, Ministry of Economic Transformation</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the high rates of  AIDS-related deaths and accelerate the reduction in new HIV infections. Objectives: To rapidly scale up differentiated and innovative approaches for prevention of HIV among key and vulnerable populations and optimize linkage to care, retention and adherence among PLHIV to achieve the 95-95-95 targets; To strengthen health and community systemsfor equitable access to integrated people-centred health services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>Ministry of Economic Transformation</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>Ministry of Economic Transformation</narrative>
    </participating-org>
    <other-identifier ref="BLZ-H-METP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-01-01" />
    <activity-date type="2" iso-date="2025-01-01" />
    <activity-date type="3" iso-date="2027-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Marcos Patino Mayer</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>marcos.patinomayer@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BZ" percentage="100">
      <narrative>Belize</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="52.82">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="47.18">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="13.35">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="1.61">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.94">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="16.58">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="3.69">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.77">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="1.36">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.52">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="4.39">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="3.79">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="39.97">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="e7ae970e-44ac-44a1-b3e1-cbff96079a5d" percentage="1.55">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing data and analytics</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="2.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="69e672f0-6d26-46e7-8e97-fcb0b6526cb4" percentage="1.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="4.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="1.81">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.99">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">866124.80</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">908948.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">815093.22</value>
    </budget>
    <capital-spend percentage="3.21" />
    <transaction ref="0a319aeb-1b2d-44c2-86c2-449a58d1f607">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">55171.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9060621-05ff-49be-852d-6dc676ece7ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-04" />
      <value currency="USD" value-date="2024-11-04">55171.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-H-METP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dc85d8a5-fb1b-43bb-8225-bce7a33d6908">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-03" />
      <value currency="USD" value-date="2025-01-03">1423944.65</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a74a0650-ce86-4dcb-96ae-235403619bca">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">898418.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-H-METP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4565cea9-35d5-47be-9405-625576f3a0a3">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-16" />
      <value currency="USD" value-date="2025-09-16">24329.58</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="09bab75d-25ff-4d46-ad25-e28f2340d3bd">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">-525526.65</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f64cc638-cd6f-495f-8a0e-4e19d60ce8de">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">525527.65</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4463ee44-6b6e-4ba9-b2d1-9653317ff6f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">525526.65</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-H-METP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6bc37dcd-af06-4adc-9979-f13961ab464e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">18178.90</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-H-METP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="75d8696c-5d73-429b-a8a9-9b543ffda225">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-22" />
      <value currency="USD" value-date="2026-04-22">587152.90</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b13f9b33-d36a-41dd-8f44-4113b6663e28">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-22" />
      <value currency="USD" value-date="2026-04-22">-1.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="814051f9-82ce-474e-9f31-a60fab2200c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">383379.60</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-H-METP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="17277045-d4e3-4afc-89f0-795ae1465aad">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-09" />
      <value currency="USD" value-date="2026-07-09">-6150.68</value>
      <description>
        <narrative>Global Fund commitment to BLZ-H-METP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Ministry of Economic Transformation</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BLZ-H-MET" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-13" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 603,823 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.1(1)(a) and 6.1(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the co-financing commitment Letter to be signed by the Government of Belize and submitted in form and substance satisfactory to the Global Fund by 31 January 2025: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV for the upcoming year; and ii. the total expenditure for HIV in the previous fiscal year.</narrative>
      </condition>
      <condition type="2">
        <narrative>2 - Conditions to the use of Grant Funds (1) Prior to the use of Grant Funds by the Principal Recipient to finance the activities specified below, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, the following: a) Prior to the use of USD 33,750 in connection with the purchase of IT equipment, software and applications for RSSH Routine Reporting under budget lines 105 and 122 of the detailed budget for this Grant (the “Detailed Budget”): the corresponding terms of reference. b) Prior to the use of USD 60,000 in connection with travel-related costs linked to international travel under budget lines 130 and 132 of the Detailed Budget: relevant terms of reference of said international travel. c) Prior to the use of USD 220,732 in connection with the engagement of technical assistance under budget lines 82, 101, 131 and 133 of the Detailed Budget: evidence that the Operational Manual contains competitive process requirements that are aligned with Global Fund’s Grant Regulations and Operational Guidelines for Grant Budgeting (both, as amended from time to time). Furthermore, the Principal Recipient shall submit the relevant terms of reference applicable to the providers of the technical assistance in the above budget lines; d) Prior to the use of USD 25,125 in connection with the purchase of rapid diagnostic tests under budget line 2 of the Detailed Budget: an updated quantification for health products, prepared with technical assistance from PAHO; e) Prior to the use of USD 68,850 in connection with the NAC M&amp;E position under budget line 108 of the Detailed Budget: evidence that there is an absorption plan in place, including at least 50% absorption for year 3 of the Implementation Period; f) Prior to the use of USD 51,450 in connection with office-related costs for GoJoven Belize under budget line 121 of the Detailed Budget: adequate justification on the duplication of overhead costs in comparison with GC6; and g) Prior to the use of USD 26,323 in connection with the salary incentives applicable to the employment of a finance officer under budget line 113 of the Detailed Budget, detailed justification on the level of effort required for year 2 and year 3 of the Implementation Period.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of individual HIV self-test kits distributed</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of individual HIV self-test kits distributed</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="298" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2550" />
          <actual value="1180" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="3133" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="3049" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="27.75">
          <comment>
            <narrative>Numerator: 1049; Denominator: 3780.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2457; Denominator: 3780.</narrative>
            </comment>
          </target>
          <actual value="57.83">
            <comment>
              <narrative>Numerator: 2186; Denominator: 3780.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 2835; Denominator: 3780.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 3213; Denominator: 3780.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="39" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93" />
          <actual value="121" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="157" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="217" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="26.67">
          <comment>
            <narrative>Numerator: 1008; Denominator: 3780.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 1890; Denominator: 3780.</narrative>
            </comment>
          </target>
          <actual value="53.07">
            <comment>
              <narrative>Numerator: 2006; Denominator: 3780.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2457; Denominator: 3780.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 3024; Denominator: 3780.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="86.07">
          <comment>
            <narrative>Numerator: 1520; Denominator: 1766.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="88.04">
            <comment>
              <narrative>Numerator: 1965; Denominator: 2232.</narrative>
            </comment>
          </target>
          <actual value="82.03">
            <comment>
              <narrative>Numerator: 1173; Denominator: 1430.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 2267; Denominator: 2464.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 2578; Denominator: 2713.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="48.68">
          <comment>
            <narrative>Numerator: 1766; Denominator: 3628.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 2232; Denominator: 3720.</narrative>
            </comment>
          </target>
          <actual value="41.04">
            <comment>
              <narrative>Numerator: 1623; Denominator: 3955.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2464; Denominator: 3791.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="70.01">
            <comment>
              <narrative>Numerator: 2713; Denominator: 3875.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>